Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
UK’s First Real-World Evidence Guideline Targets Randomized Trials
Oct 30 2020
•
By
Vibha Sharma
Randomized trials using RWD are most likely to be considered for label changes • Source: Shutterstock
More from Real-World Evidence
More from Clinical Trials